the genes specify the number and positions of tracheal position 92B and failed to complement each other for lethality or the tracheal function. At stage 16 in wild-type branches and their direction of outgrowth is not known.
Here, we describe a new gene branchless (bnl), which, embryos, primary branches have budded and grown out from the tracheal sacs, secondary and some terminal like btl, is required for the earliest tracheal branching events. We show that bnl encodes a protein homologous branches have formed, and branch fusion has taken place to form the dorsal and lateral tracheal trunks ( Figure 1C ). to FGFs that appears to function as a ligand for the Btl receptor. bnl is expressed dynamically at specific
In bnl P1 mutants, none of these events occurred normally: almost every tracheal metamere appeared as an unpositions surrounding the tracheal sacs, where it induces the formation and attracts the outgrowth of pribranched, elongate sac of tracheal cells ( Figure 1D ). Staining and live imaging of tracheal development in earlier mary branches. This result and others demonstrate that bnl provides instructive inductive and guidance cues embryos showed that tracheal cells invaginated and formed tracheal sacs normally in bnl P1 mutants, but to developing tracheal cells. bnl also serves a second patterning function by activating later programs of trabranches failed to grow out ( Figure 1B ; data not shown). Most other aspects of embryonic development were unafcheal gene expression in cells that go on to form secondary and terminal branches. The results suggest that an fected, including expression of engrailed ( Figure 1J ) and formation of muscles (not shown) and the peripheral ner-FGF-signaling pathway controls the tracheal branching pattern, and that the patterning information is encoded vous system ( Figure 1L ). However, as with btl mutations, specific defects in the central nervous system were found in the complex and dynamic expression of the ligand in tissues surrounding the developing tracheal system. and will be described elsewhere.
Hemizygous mutants (bnl

P1
/Df(3R)DlBX12) displayed a very similar phenotype to bnl P1 homozygotes, indicatResults ing that bnl P1 is a null or strong loss-of-function allele. Homozygous bnl P2 embryos displayed sporadic defects Identification and Genetic Characterization of bnl In a screen of P transposon-induced enhancer trap mutain primary, secondary, and terminal branch formation and outgrowth ( Figure 1E ). These phenotypes were more tions, several lethal mutations were found that reduced or eliminated tracheal branching, just like btl mutations. Two severe when bnl P2 was in trans to the bnl P1 allele or a deficiency that removes the locus ( Figure 1F ; data not of the mutations, bnl P1 and bnl P2 , mapped to cytological shown). Thus, bnl P2 is a partial loss-of-function allele. The bnl locus is haploinsufficient: two-thirds of all embryos heterozygous for bnl P1 or the deficiency showed occasional missing or stalled branches, with the ganglionic branches affected most often ( Figures 1G and 1H ).
bnl Encodes an FGF Homolog Excision of the P element in the bnl P1 strain reverted the phenotype, confirming that the P element caused the bnl phenotype. Genomic DNA flanking the bnl P1 and bnl
P2
P elements was recovered and used to characterize the bnl locus. The P element insertion sites are separated by ‫31ف‬ kb (Figure 2A ). An 8 kb genomic Hind III fragment between the two insertion sites hybridized to a ‫4ف‬ kb band on Northern blots of embryonic RNA. Expression was first detected at 1.5-5 hr of development, peaked at 5-11 hr, was present at reduced levels at 11-16 hr, and was undetectable thereafter (data not shown). Eleven cross-hybridizing cDNAs were isolated, and the exons of the longest cDNA ‫7.2ف(‬ kb) were mapped on the genomic sequences ( Figure 2A ). The bnl P1 insertion is in the first intron, and the bnl P2 insertion lies ‫8ف‬ kb upstream of the cDNA.
Several lines of evidence established that this is the bnl transcription unit. First, the RNA was expressed in the same pattern as the bnl P2 enhancer trap marker, and this pattern precisely coincided with the tracheal defects in the mutants (see below). Second, the localized RNA expression was disrupted in bnl P1 homozygotes (data not shown). Third, the cDNA can restore branching in bnl mutants (see below).
We sequenced the longest cDNA and found a 2310 nucleotide open reading frame that predicts a 770 residue protein with a mass of 84 kDa (Figure 3 ). There are multiple in-frame stop codons flanking the assigned translation start and stop codons, indicating that this represents the complete bnl coding sequence. A BLAST search of the National Center for Biotechnology Informa- anonymous open-reading frame in a baculovirus (Ayres et al., 1994) .
peptide at the N-terminus, suggesting that it is secreted.
Gray boxes, identities with Bnl; open asterisks, residues conserved Bnl is unusual in that it contains large domains flanking in at least seven of nine mammalian FGFs; closed asterisks, residues the FGF domain not found in the mammalian proteins also conserved in Bnl; underlined residues, the 12 ␤ strands (1-12) ( Figure 2C ). These extensions contain several stretches in the three-dimensional structures of hFGF1 and hFGF2 (Zhu et al., of repeated amino acids, including runs of serine and 1991). Open triangles, intron positions in bnl.
glutamine, but are otherwise unrelated to known pro- Underlined amino acids, predicted signal peptide; amino acids in bold, region of homology to FGFs; codons in bold, in-frame stop codons preceding and following the coding sequence; triangles, positions of identified introns in bnl. The polyA ϩ consensus signal (bracket) indicates that the cDNA is essentially complete at its 3Ј end but is missing ‫1ف‬ kb of 5Ј leader sequence.
grow, suggesting that Bnl is an attractive factor that Although in many positions the bnl-expressing cells are very close to and probably directly contact tracheal induces and guides the outgrowth of the major branches.
cells, in other positions (e.g., clusters 1, 6, and 7), the expressing cells are initially one or several cell diameters The bnl expression pattern is shown in Figure 4 , and expression in a typical hemisegment is summarized in away from the tracheal cells that they influence (Figures 4H and 4J) . This suggests that the bnl signal may be Figure 4O . The expression pattern is complex and dynamic. At stage 11, just before tracheal branching bediffusible. gins, bnl expression appears in five small clusters of epidermal cells arrayed around the tracheal sac, at the Localized bnl Expression Induces and Directs the Outgrowth of Primary Branches positions where five primary tracheal branches will soon bud ( Figures 4D, 4G , and 4H). A sixth cluster of mesoderThe expression of bnl at all positions of branch formation and outgrowth suggested that bnl induces formation of mal cells also starts to express bnl at around the same time, near the position where the sixth primary branch primary branches and directs them to their targets. To test this hypothesis, we used the GAL4-UAS expression is forming ( Figure 4M ). As the primary branches grow by cell migration over the next 2 hr (stages 12 and 13), system (Brand and Perrimon, 1993) to express Bnl protein at new positions in the embryo and then examined expression in the clusters decreases. This appears to occur in a specific spatial pattern: the bnl-expressing the effects on branching.
In bnl P1 mutants, few primary branches form, and the cells closest to or contacting the growing tracheal branches lose expression first, with the tracheal cells rare branches observed were rudimentary. However, when bnl expression was restored in the mutants at continuing to migrate toward the remaining bnl-expressing cells (e.g., compare clusters 1, 2, and 3Ј in Figure  a novel segmental position using the GAL4 driver line C49::GAL4 ( Figure 5A ), a new branch formed and grew 4H and 4I). Two more clusters of cells (7 and 8) begin expressing bnl as expression in the other clusters turns toward the positions of the ectopic bnl-expressing cells ( Figure 5B ). New branches were observed only in aboff, presaging the subsequent outgrowth of specific branches ( Figures 4J-4L ). For example, the ganglionic dominal segments, where the GAL4 driver is expressed, and never in thoracic segments, which do not express branch, which initially grows toward cluster 5, continues toward cluster 7 to reach the central nervous system
GAL4. These results demonstrate that bnl is a localized inducer of tracheal branching and can direct outgrowth (Figures 4J and 4K) . A final example of the correspondence between tracheal growth and bnl expression is to novel positions. However, new branches were not induced in the sixth and seventh abdominal segments, shown in Figure 4N , where a tract of bnl-expressing cells in the head marks the path of the pharyngeal branch.
despite the presence of bnl-expressing cells, suggesting We also tested the effect of ectopically expressing 5D). When bnl was expressed throughout the embryo under control of a heat-shock GAL4 driver or other bnl in the background of wild-type bnl expression and found that it disrupted the normal pattern of branching.
widely expressed GAL4 drivers, tracheal branching was dramatically altered. Growth of most primary branches When bnl was misexpressed using the C49::GAL4 driver, The GAL4-UAS expression system was used to misexpress bnl in small patches using the C49::GAL4 driver (A-D) or more generally throughout the animal using the hsGAL4 or 69B::GAL4 drivers (F and H). (A) UASlacZ; C49::GAL4 embryo was stained for ␤ galactosidase to show the expression pattern of the C49::GAL4 driver. ␤ galactosidase is expressed at stages 12 and 13 in a discrete patch (bracket) in each abdominal segment (A1-A6) but not in thoracic segments (T3). was arrested ( Figure 5F ), and persistent ectopic expresbnl P1 mutants ( Figure 6B ; data not shown). In contrast, in embryos that ectopically expressed bnl, both markers sion of bnl transformed the stunted branches into a mass of fine branches growing out in random directions were activated throughout the tracheal system ( Figures  6C and 6E) , and the expressing cells later gave rise ( Figure 5H ).
From these misexpression studies, we conclude that to secondary and terminal branches ( Figure 6F ). These results support the hypothesis that bnl expression near the normal spatially restricted pattern of bnl is essential for the normal pattern of branching, and that the localthe ends of the primary branches not only guides primary branch outgrowth but also activates the program of secized domains of bnl expression induce formation of primary branches and direct them to their proper positions.
ondary and terminal branching in cells at these positions. bnl Activates Later Programs of Tracheal Branching Secondary branches sprout from the ends of primary bnl Acts through the btl Receptor branches and from a few internal positions. bnl is ex-
The identity of bnl and btl gene products as homologs pressed near positions where secondary branch markof FGFs and FGFRs, taken with their complementary ers begin to be expressed ( Figure 6A ), suggesting that expression patterns during tracheal development and bnl might also play a role in selecting where secondary their similar mutant phenotypes, strongly suggested that branches sprout. Consistent with this idea, the weak Bnl is a ligand of the Btl receptor. The following genetic allele bnl P2 showed defects in secondary as well as priand biochemical experiments substantiated this hymary branching. Moreover, the extensive networks of pothesis. fine branches that resulted from generalized misexpresFirst, we found that btl LG18 bnl P1 double mutants exhibsion of bnl resembled secondary and terminal branches.
ited a tracheal phenotype similar to either loss-of-funcTo define the role of bnl in later branching events, tion mutant alone ( Figure 7B ), as expected if the two we assayed expression of secondary (pnt) and terminal genes function in the same signaling pathway. Genes (pruned/DSRF) branch genes in bnl loss-of-function muin the same signaling pathway also commonly display tants and in embryos that ectopically expressed bnl dosage-sensitive interactions, and we found such interthroughout the embryo. We found that pnt and pruned/ DSRF failed to be expressed in the tracheal system of actions between bnl and btl. bnl is a haploinsufficient locus; therefore, its products must be present at a limbtl LG19 mutants alone (data not shown). These epistasis experiments place bnl genetically upstream of (or paraliting concentration in heterozygous (bnl P1 /ϩ) individuals (see Figure 1H ). Although btl is not haploinsufficient, a lel to) btl, the expected relationship for a ligand and its receptor. 50% reduction in the dosage of btl (btl LG19 /ϩ) in a bnl P1 /ϩ heterozygote enhanced the phenotype such that every Finally, we showed that Bnl can activate the Btl receptor in vivo. An early biochemical manifestation of activation double heterozygote showed defects in tracheal outgrowth. Thus, reduction in the level of btl can exacerbate of Btl and other FGFRs is autophosphorylation on tyrosines (Johnson and Williams, 1993; Lee et al., 1996) . the bnl-signaling defect.
Second, we found that a constitutively activated form We assayed tyrosine phosphorylation of Btl protein in embryo extracts by immunoprecipitation with an antiof the Btl receptor can partially ameliorate the effect of absence of bnl. Previously, it was shown that an actiphosphotyrosine antiserum (Lee et al., 1996) . In wildtype extracts, a low level of phosphorylated Btl was vated form of the Btl receptor (a Tor 4021 -Btl chimera) expressed under heat-shock control can partially redetected, presumably due to its activation by endogenous Bnl ( Figure 7E , lane 1). In transgenic embryos that verse the branching defects in btl loss-of-function mutants (Reichman-Fried et al., 1994) : notably, dorsal expressed bnl throughout the body, the level of phosphorylated Btl was increased ‫-8ف‬fold ( Figure 7E , lane 2). trunk branches sometimes form and fuse to their partners ( Figure 7D ). When the activated form of the receptor was expressed in bnl P1 mutants, the same effect Discussion was observed ( Figure 7C ). The modest restoration of branching obtained in these experiments presumably While much has been learned about how the major body axes are patterned, the developmental mechanisms and reflects the fact that the normal spatial distribution of activated receptor is not restored under these condimolecules that pattern complex organ structures like the lung and the tracheal system have remained an tions (see Discussion). We also found that the btl
LG19 lossof-function mutation prevented the excessive branching enigma. Our genetic and molecular characterization of bnl has identified it as an inducer and key regulator of induced by generalized expression of bnl, looking like tracheal branching at the ends of growing primary branches.
A Molecular Basis for Tracheal Branch Patterning
The evidence that bnl is a key regulator of tracheal branching is as follows. First, a bnl loss-of-function mutation prevents branch formation. Second, bnl is expressed in localized patches that predict the positions where new branches will form and the direction in which they will grow. Budding branches grow toward and contact the cells that express bnl. Third, localized misexpression of bnl can induce branch formation and outgrowth to new positions. Fourth, generalized misexpression of the gene leads to a massive proliferation of branches.
The results lead us to propose that bnl provides the molecular basis for tracheal branch patterning, with the localized bnl expression domains specifying where primary branches bud and the directions in which they migrate. We further propose that the positions of persistent bnl expression dictate where secondary and ultimately terminal branches bud. According to our model, the elaborate three-dimensional structure of the tracheal system is encoded in the complex expression of bnl in tissues surrounding the developing tracheal cells. This model is also supported by recent studies of the effects of a constitutively activated Btl receptor on tracheal development (Lee et al., 1996) .
A striking feature of the bnl expression pattern is its spatial complexity, one of the most complex patterns ries of such signals along their outgrowth pathways.
Evidence for Additional Branch-Patterning Factors tracheal branching. The complex and dynamic expression of bnl in the embryo prefigures the tracheal system While the results establish bnl as a primary determinant of the tracheal branching pattern, they also suggest the and provides the spatial cues that specify the general branching pattern. Furthermore, the discovery that bnl existence of additional factors that may modulate the effects of bnl or function with it to specify the branching encodes an FGF homolog that functions with the btl FGFR begins to elucidate at the cellular and molecular pattern. Whereas the developing tracheal cells in most segments responded to an ectopic patch of bnl expreslevel how an FGF-signaling pathway controls morphogenesis. bnl regulates tracheal branching in two distinct sion by forming a branch that grew toward the expressing cells, the tracheal cells in two posterior metameres ways: by guiding tracheal cell migration during primary branch formation and then inducing later programs of did not form a new branch. We also observed in this experiment that all of the branches grew anteriorly toWhile we favor a chemoattractant function for Bnl, the data do not exclude the possibility that the protein is ward an ectopic patch of bnl-expressing cells, and none of the branches grew posteriorly toward the next segretained on the surface of expressing cells and that its orienting activity is achieved by stabilization of randomly mental patch, although it was a similar distance away. Other factors must influence the reception of the bnl directed tracheal outgrowths. Recent studies of neuronal outgrowth in the Xenopus signal by tracheal cells or their response to it. Inhibitory factors at inter-or intrasegmental boundaries, for examvisual system (McFarlane et al., 1995) and studies of FGFR mutants in Drosophila and C. elegans indicate that ple, might prevent diffusion of Bnl or growth of branches across the boundary. Another pertinent finding is that control of cell migration may be a generally important function of FGF-signaling pathways in vivo. In addition in btl and bnl mutants, expression of a constitutively activated Btl receptor sporadically restored outgrowth to its tracheal expression, the Btl receptor is expressed in the border cells of the ovary and in specific central and fusion of dorsal trunk branches. While the loss-offunction mutants show that bnl and btl are required nervous system glial cells, where it is also implicated in cell migration (Klambt et al., 1992; Murphy et al., 1995) . for the growth of these branches, the results with this activated receptor indicate that localized activation of A second FGFR homolog in Drosophila has recently been found to be necessary for mesodermal cell migrathe receptor by Bnl may not always be essential. There might be an additional factor that provides spatial infortion (B. Shilo and A. Michelson, personal communication), and the egl-15 FGFR homolog in C. elegans is mation to the growing dorsal trunk branches. This would explain the earlier conclusion that Btl has only a permisrequired for proper migration of the sex myoblasts (DeVore et al., 1995) . It will be interesting to identify the sive role for these branches (Reichman-Fried et al., 1994) , while for most other branches, Bnl and Btl appear ligands for these receptors and determine if they function as motogens and guidance molecules like Bnl. to have an instructive role (see above and Lee et al., 1996) .
Bnl as an Inducer of Later Programs of Branching During the second stage of branching, Bnl selects the Bnl as a Motogen and Guidance Molecule for Tracheal Cell Migration
positions where new branches form. Most sprout from cells at the ends of the growing primary branches, near Our analysis of bnl has begun to elucidate the function of an FGF in vivo at a level not previously possible. Bnl the domains of persistent bnl expression. The role of Bnl in the later branching events differs in many respects does not act as a mitogen or trophic factor here, as do many FGFs in vitro, because tracheal branching involves from its function during primary branching. First, Bnl does not appear to guide outgrowth of secondary neither cell proliferation nor cell death (Samakovlis et al., 1996) . Rather, Bnl regulates primary branching by branches: bnl mRNA expression is mostly off when the secondary branches actually form, and its earlier excontrolling tracheal cell migration. Primary branches begin to form when one or two tracheal cells starts to pression does not correlate simply with the direction in which these branches grow. Also, morphogenesis of migrate toward a cluster of bnl-expressing cells, and additional tracheal cells follow, organizing into a tubular these branches occurs by individual tracheal cells rounding up into tubes, rather than by groups of cells structure as they migrate. bnl is required for these migrations, and it can direct migration to new positions. Thus, organizing into multicellular tubes as during primary branching. Finally, expression of new sets of genes is Bnl is a motogen that stimulates and guides tracheal cell migration. Migration begins less than an hour after required to form secondary and terminal branches, and we have shown here that bnl is necessary and sufficient bnl RNA is detected in the nearby cells. This rapid response suggests that Bnl protein may stimulate migrato induce their expression. We suggest that this gene induction is the critical and perhaps sole function of Bnl tion by modulating preexisting factors such as cytoskeletal components in the responding cells, rather than by during secondary branching. The same tracheal cells respond in two very different induction of new gene expression. A major goal now is to define the intracellular events that follow receptor ways to the same ligand (Bnl) through the same receptor (Btl) over several hours. Initially, the cells migrate toward activation; our recent identification of a new gene called stumps, which functions genetically downstream of bnl the ligand and organize into multicellular tubes. But 2 hr later, the cells at the end of the branch are induced and btl, provides an entry to such studies.
Bnl functions as a short-range signal for tracheal cell to form secondary and ultimately terminal branches. What distinguishes the tracheal cells' response during migration. In many instances, the bnl-expressing cells directly contact the cells that they influence. In other this time? The requirement for new gene expression for the later branching events may explain both the delay positions, the expressing cells appear to be up to several cell diameters away, suggesting that Bnl protein may in secondary branching and the different early and late effects of Bnl. Secondary branching genes, such as pnt, be a diffusible chemoattractant, as has been observed for mammalian FGFs in cell culture (Terranova et al., begin to be expressed as the cells start to migrate and form primary branches. Once synthesis of the induced 1985). As expected for a chemoattractant, the concentration of Bnl is critical for migration: migration of tragene products is complete, tracheal cells may be committed to forming a different type of branch. This could cheal branches, especially those farthest from the signaling cells, was sensitive to a 50% reduction in bnl also explain why persistent signaling appears to be necessary for the later stages of branching, as it may allow gene dosage. Moreover, ubiquitous expression of bnl dramatically inhibited primary branch outgrowth, prefor sufficient accumulation of the induced gene products. The temporal delay imposed by a round of gene sumably by obliterating the Bnl concentration gradient. from 2-2.7 kb; all cross-hybridized and contained an internal EcoRI expression is an elegant way of coordinating early and restriction site. Genomic phage were isolated from an EMBL3 library late stages of branching and ensuring that the smaller (from J. Tamkun) using bnl cDNA Z3-2 as a probe. secondary branches form after the larger primary
The bnl cDNA Z3-2 was subcloned into pBluescript (Stratagene) branches and at their growing ends.
to give plasmid pDS7006. A deletion series was generated and used for chain termination sequencing. Some sequence was also obtained using Taq-polymerase cycle sequencing and an automated Do FGFs Control Branch Patterning of Other Organs?
sequencer. To define intron/exon boundaries, the relevant genomic Like the tracheal system, the major branches of many fragments were subcloned into pBluescript and sequenced. mammalian organs, including the lung, kidney, and most glandular structures, display complex, characteristic Misexpression of bnl In Vivo branching patterns. Despite the success in the past decDNA Z3-2 was inserted into the EcoRI-XhoI sites of pUAST (Brand cade in isolating a number of inducers of branching, it and Perrimon, 1993) . The resultant plasmid, pUAST-bnl, was introremains unknown how these or any other molecules duced into w 1118 animals by P element transformation using p⌬2-3 specify the number, position, and direction of branches.
helper plasmid. Six independent lines were established. Initial tests with three lines (UASbnlA1-1, UASbnlA1-2, and UASbnlB4-2) gave
We speculate that the general branching patterns of essentially identical effects on branching. For convenience, an X some of these organs might be specified analogously chromosome insertion (UASbnlB4-2) was used in most experiments to the tracheal system by the expression of branch inexcept the Btl phosphorylation experiments in which a second chroducers in complex patterns that prefigure branching.
mosome insertion (UASbnlA1-2) was used. The GAL4 driver line Intriguingly, the mouse FGF7 gene is expressed in an C49::GAL4 was a gift from D. Lin; hsGAL4 and 69B::GAL4 are deintricate pattern in the mesenchymal tissue of the develscribed on Flybase. GAL4 expression patterns were determined by ␤ galactosidase-staining of embryos carrying a GAL4 driver and a oping lung, apparently near positions of epithelial UASlacZ construct (Brand and Perrimon, 1993) .
branching, and generalized misexpression of the gene
To induce expression of hsGAL4, embryos were collected for ‫21ف‬ disrupts branching (Mason et al., 1994; Simonet et al., hr at room temperature, washed into miniature baskets, submerged 1995 , 1994) . Homozygous bnl P1 embryos carrying one copy of the l(3)0857 and l(3)6916 from A. Spradling (Spradling et al., 1995) . The construct were collected for 1 hr at room temperature, aged for 4 bnl P1 P element has an internal deletion that removes most of the hr at 25ЊC, and then heat shocked as described above for 20 min bacterial kan r gene and ori region. Introduction of a source of transto induce expression of the transgene. After 30 min recovery at 18ЊC posase (TMS⌬2-3 chromosome) into the bnl P1 strain yielded a homofollowed by 75 min at 25ЊC, a second heat shock was given, and zygous viable revertant (#26) that restored tracheal branching as development continued for 14 hr at 18ЊC before staining with well as other incomplete revertants with intermediate tracheal pheMAb2A12. notypes. btl
LG18 and btl LG19 are null or strong loss-of-function alleles bnl was ubiquitously expressed in btl LG19 embryos using embryos (Klambt et al., 1992) . Df(3R)DlBX12 and the enhancer trap markers from a cross of UASbnlB4-2/UASbnlB4-2; btl LG19 /TM3 females and in trachealess (1-eve-1) and pnt (Pantip-1 l(3)7825) have been dehsGAL4/ϩ; btl LG19 /ϩ males and following the standard heat-shock scribed (Perrimon et al., 1991; Lindsley and Zimm, 1992 ; Samakovlis regimen described in the previous section. et al., 1996) .
For the phosphotyrosine analysis, embryos from a cross of UASbnlA1-2/Cyo females and hsGAL4/hsGAL4 males, or from the parenEmbryo Staining and In Situ Hybridization tal w 1118 strain as control, were collected for 10 hr at room temperaAntibodies and embryo fixation and staining procedures have been ture, heat shocked twice for 20 min as described above, with 1 hr described (Samakovlis et al., 1996) . Other antibodies were: the antirecovery, and allowed to develop for 5 hr at 29ЊC. Phosphotyrosine Engrailed MAb4D9, the peripheral nervous system marker MAbanalysis of Btl followed the protocol of Lee et al. (1996) , except 22C10, antimuscle myosin MAbFMM5 from D. Kiehart, anti-DSRF that a biotinylated secondary antibody, avidin-HRP, and enhanced MAb2-161 from M. Gilman.
chemiluminescence were used to amplify the Btl signal on Western In situ hybridization of whole-mount embryos was done with diblots. goxigenin-labeled RNA probes for the sense strand of bnl cDNA Z3-2 followed by alkaline phosphatase immunohistochemistry (O'Neill and Bier, 1994) . Control experiments using probes for the Acknowledgments antisense strand detected no signal. RNA and antibody double stains were done as described (Kopczynski et al., 1996) .
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